These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1498951)

  • 21. Specificity of 6-hydroxydopamine-induced destruction of mesolimbic or nigrostriatal dopamine-containing terminals.
    Kelly PH; Joyce EM; Minneman KP; Phillipson OT
    Brain Res; 1977 Feb; 122(2):382-7. PubMed ID: 189878
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute restraint stress prevents nicotine-induced mesolimbic dopaminergic activation via a corticosterone-mediated mechanism: a microdialysis study in the rat.
    Enrico P; Sirca D; Mereu M; Peana AT; Mercante B; Diana M
    Drug Alcohol Depend; 2013 Jan; 127(1-3):8-14. PubMed ID: 22809896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortico-subcortical interactions in behavioral sensitization: differential effects of daily nicotine and morphine.
    Tassin JP; Vezina P; Trovero F; Blanc G; Hervé D; Glowinski J
    Ann N Y Acad Sci; 1992 Jun; 654():101-16. PubMed ID: 1632576
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection.
    Fuxe K; Janson AM; Jansson A; Andersson K; Eneroth P; Agnati LF
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):171-81. PubMed ID: 2342600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The debate over dopamine's role in reward: the case for incentive salience.
    Berridge KC
    Psychopharmacology (Berl); 2007 Apr; 191(3):391-431. PubMed ID: 17072591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between cholinergic and catecholaminergic neurones in rat brain.
    Corrodi H; Fuxe K; Lidbrink P
    Brain Res; 1972 Aug; 43(2):397-416. PubMed ID: 4403347
    [No Abstract]   [Full Text] [Related]  

  • 27. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine.
    Corrigall WA; Franklin KB; Coen KM; Clarke PB
    Psychopharmacology (Berl); 1992; 107(2-3):285-9. PubMed ID: 1615127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of alpha7 nicotinic receptors in the ventral tegmental area.
    Schilström B; Svensson HM; Svensson TH; Nomikos GG
    Neuroscience; 1998 Aug; 85(4):1005-9. PubMed ID: 9681941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic studies of ethanol's interaction with the mesolimbic dopamine reward system.
    Söderpalm B; Löf E; Ericson M
    Pharmacopsychiatry; 2009 May; 42 Suppl 1():S87-94. PubMed ID: 19434560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats.
    Imperato A; Mulas A; Di Chiara G
    Eur J Pharmacol; 1986 Dec; 132(2-3):337-8. PubMed ID: 3816984
    [No Abstract]   [Full Text] [Related]  

  • 31. CART peptide increases the mesolimbic dopaminergic neuronal activity: a microdialysis study.
    Yang SC; Pan JT; Li HY
    Eur J Pharmacol; 2004 Jun; 494(2-3):179-82. PubMed ID: 15212972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study.
    Yin R; French ED
    Brain Res Bull; 2000 Apr; 51(6):507-14. PubMed ID: 10758341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging.
    Due DL; Huettel SA; Hall WG; Rubin DC
    Am J Psychiatry; 2002 Jun; 159(6):954-60. PubMed ID: 12042183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient changes in mesolimbic dopamine and their association with 'reward'.
    Wightman RM; Robinson DL
    J Neurochem; 2002 Aug; 82(4):721-35. PubMed ID: 12358778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons.
    Clarke PB; Pert A
    Brain Res; 1985 Dec; 348(2):355-8. PubMed ID: 4075093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological processes underlying co-use of alcohol and nicotine: neuronal mechanisms, cross-tolerance, and genetic factors.
    Funk D; Marinelli PW; Lê AD
    Alcohol Res Health; 2006; 29(3):186-92. PubMed ID: 17373407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields.
    Dilts RP; Helton TE; McGinty JF
    Synapse; 1993 Mar; 13(3):251-63. PubMed ID: 8497810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area.
    Corrigall WA; Coen KM; Adamson KL
    Brain Res; 1994 Aug; 653(1-2):278-84. PubMed ID: 7982062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aversive stimuli and loss in the mesocorticolimbic dopamine system.
    Brooks AM; Berns GS
    Trends Cogn Sci; 2013 Jun; 17(6):281-6. PubMed ID: 23623264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats.
    Navarro M; de Miguel R; Rodríguez de Fonseca F; Ramos JA; Fernández-Ruiz JJ
    Behav Brain Res; 1996 Feb; 75(1-2):91-8. PubMed ID: 8800663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.